Brighton Jones LLC Repligen Corp Transaction History

Brighton Jones LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$138.78 - $176.51 $10,547 - $13,414	-76 Reduced 2.56%	2,889 $459,000
Q2 2023 Jul 31, 2023	SELL	$138.42 - $180.31 $692 - $901	-5 Reduced 0.17%	2,965 $419,000
Q1 2023 May 08, 2023	BUY	$154.26 - $198.1 $458,152 - $588,357	2,970 New	2,970 $500,000

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.